0001104659-19-008738.txt : 20190214
0001104659-19-008738.hdr.sgml : 20190214
20190214162041
ACCESSION NUMBER: 0001104659-19-008738
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
EFFECTIVENESS DATE: 20190214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Samsara BioCapital, LLC
CENTRAL INDEX KEY: 0001744967
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19375
FILM NUMBER: 19606695
BUSINESS ADDRESS:
STREET 1: 628 MIDDLEFIELD ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 285-4270
MAIL ADDRESS:
STREET 1: 628 MIDDLEFIELD ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94301
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001744967
XXXXXXXX
12-31-2018
12-31-2018
false
Samsara BioCapital, LLC
628 Middlefield Road
Palo Alto
CA
94301
13F HOLDINGS REPORT
028-19375
N
Richard Van Doren
Chief Compliance Officer
650-285-4270
/s/ Richard Van Doren
Palo Alto
CA
02-14-2019
0
17
104184
false
INFORMATION TABLE
2
a19-4733_1informationtable.xml
INFORMATION TABLE
Allakos Inc
COM
01671P100
23959
458366
SH
SOLE
458366
0
0
Aravive Inc
COM
03890D108
1558
442733
SH
SOLE
442733
0
0
Catabasis Pharmaceuticals Inc
COM
14875P206
1311
300000
SH
SOLE
300000
0
0
Edge Therapeutics Inc
COM
279870109
59
183332
SH
SOLE
183332
0
0
Evelo Biosciences Inc
COM
299734103
2960
227529
SH
SOLE
227529
0
0
Intercept Pharmaceuticals Inc
COM
45845P108
23623
234375
SH
SOLE
234375
0
0
KalVista Pharmaceuticals Inc
COM
483497103
2963
150000
SH
SOLE
150000
0
0
Liquidia Technologies Inc
COM
53635D202
8197
378420
SH
SOLE
378420
0
0
Millendo Therapeutics Inc
COM
60040X103
359
45101
SH
SOLE
45101
0
0
Miragen Therapeutics Inc
COM
60463E103
2755
909090
SH
SOLE
909090
0
0
Odonate Therapeutics Inc
COM
676079106
8390
595850
SH
SOLE
595850
0
0
Principia Biopharma Inc
COM
74257L108
10504
383480
SH
SOLE
383480
0
0
Surface Oncology Inc
COM
86877M209
332
78300
SH
SOLE
78300
0
0
Sutro BioPharma Inc
COM
869367102
10153
1125576
SH
SOLE
1125579
0
0
Syros Pharmaceuticals Inc
COM
87184Q107
5904
1059938
SH
SOLE
1059938
0
0
Trillium Therapeutics Inc
COM
89620X506
122
71619
SH
SOLE
71619
0
0
Urovant Sciences Ltd
COM
G9381B108
1038
157480
SH
SOLE
157480
0
0